Dr. Sanford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1309 W 17th St
Sioux Falls, SD 57105Phone+1 605-328-8000Fax+1 605-328-8000
Summary
- Amy Sanford, MD is an Oncologist based in Sioux Falls, SD. She completed her Fellowship in Hematology and Medical Oncology and a Residency in Internal Medicine from the University of Iowa Hospitals and Clinics between 2009 to 2015, following her graduation from the University of South Dakota, Sanford School of Medicine in 2009. Dr. Sanford has contributed to the medical field through her numerous publications, including significant works published in South Dakota Medicine, Molecular and Cellular Biology, Blood, and Comparative Medicine, some of which have been cited numerous times by other professionals in her field.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2012 - 2015- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2009 - 2012
University of South Dakota, Sanford School of MedicineClass of 2009
Certifications & Licensure
SD State Medical License Active through 2027
IA State Medical License 2009 - 2025
MN State Medical License 2020 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 122 citationsPembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Non...Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost, Valeriy Breder, Dariusz M. Kowalski
JAMA Oncology. 2021-06-04 - 1 citationsA Very Rare Case of Sarcoid-Lymphoma Syndrome Imposing an Intriguing Diagnostic Challenge.Aiham H Jbeli, Ashwyna Sunassee, Amy Sanford, Ashraf Elshami, Jonathan Bleeker
South Dakota Medicine. 2018-03-01 - 64 citationsGCF2/LRRFIP1 represses tumor necrosis factor alpha expression.April R. Suriano, Amy N. Sanford, Nahmah A. Kim, Miae Oh, Sarah Kennedy
Molecular and Cellular Biology. 2005-10-15
Press Mentions
Sanford Opens I-SPY 2 Clinical Trial for Breast CancerFebruary 18th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
